Nationally ranked among the best cancer hospital in the US, our center treats a high volume of patients with many types of cancer, making it a destination center of excellence, especially for high-risk or complex cases.
You want Baylor Scott & White Charles A. Sammons Cancer Center – Dallas, a leading cancer center in North Texas.
Our unmatched cancer programs across outpatient and inpatient care make us one of the best cancer treatment centers in Texas, offering quality, coordinated cancer care in Dallas across the patient journey.
Every cancer patient has a unique set of circumstances that require a personalized plan of care. The multidisciplinary team of top cancer physicians in Dallas on the centers’ medical staffs and the oncology-trained staff across our Cancer Research and Treatment Centers and other specialized programs take your cancer treatment approach to the next level. At Baylor Scott & White Charles A. Sammons Cancer Center – Dallas, developing an innovative treatment plan involves the collaboration of the patient’s primary care physician with physicians and experts across several relevant disciplines.
During multidisciplinary tumor board conferences, difficult-to-treat patient cases are reviewed, including type and stage of malignancy, medical history, and the patient’s age and personal preferences. Our team of leading Dallas cancer specialists thoroughly discuss and evaluate treatment options and offer recommendations regarding minimally invasive treatments, surgery, or advanced and innovative techniques, including immunotherapy where appropriate.
Our Patient Navigation Program serves patients from diagnosis, throughout treatment and into survivorship. Your patient navigator will be there to offer guidance to patients and their families every step of the way.
Contact a patient navigator by calling 214.820.3535.
As a major academic medical center with a multidisciplinary team of researchers and expert cancer physicians on its medical staff, Baylor University Medical Center can access the support of Baylor Scott & White Research Institute to administer effective therapies, manufacture immunotherapy treatment and conduct lab work where patients are being treated.
Pioneering research and treatment in immunotherapies, Baylor University Medical Center was the first North Texas providers to offer adult commercial use of chimeric antigen receptor T-cell therapy, or CAR-T, to treat patients with large B-cell lymphoma and acute lymphoblastic leukemia.
The landscape of cancer care has changed drastically in the last 10 years. See how Baylor Scott & White remains a leader of cancer research advancements.
